Sometimes feels like I'm in the one universe (in the many-world interpretation) where Reme got CRL'd while a billion others were all a no-brainer go-ahead.
It's a really hard stock to stomach at times, but I really hope it gets approval for something . Not for me anymore, but for people suffering.
I mean, when I look at ruxolitinib and the ease with which they seem to be able to fly through approval it really makes me wonder...
Cell Therapy News/Articles, page-11681
-
- There are more pages in this discussion • 6,168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |